Is my portfolio
One Report to Answer all your Questions!
Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%) Dr. Reddy’s Laboratories submits press release
Date: 28-11-2024Dr. Reddy’s Laboratories has submitted a Press Release on “Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.”
The above information is a part of company’s filings submitted to BSE.